Two Roche Diagnostics Corp. executives recently spoke enthusiastically about the company's progress toward personalized health care. Central to unlocking this potential is the combination of using data from multiple sources, the use of machine learning to further knowledge and understanding and partnering with others, including non-traditional players, to combine their expertise with Roche's.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?